CN116694680A - Lactoferrin plant expression vector for stably and efficiently expressing lactoferrin gene and application - Google Patents
Lactoferrin plant expression vector for stably and efficiently expressing lactoferrin gene and application Download PDFInfo
- Publication number
- CN116694680A CN116694680A CN202310885128.XA CN202310885128A CN116694680A CN 116694680 A CN116694680 A CN 116694680A CN 202310885128 A CN202310885128 A CN 202310885128A CN 116694680 A CN116694680 A CN 116694680A
- Authority
- CN
- China
- Prior art keywords
- lactoferrin
- expression vector
- blf
- gene
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108010063045 Lactoferrin Proteins 0.000 title claims abstract description 77
- 102000010445 Lactoferrin Human genes 0.000 title claims abstract description 56
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title claims abstract description 56
- 229940078795 lactoferrin Drugs 0.000 title claims abstract description 56
- 235000021242 lactoferrin Nutrition 0.000 title claims abstract description 56
- 239000013604 expression vector Substances 0.000 title claims abstract description 36
- 230000014509 gene expression Effects 0.000 claims abstract description 46
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 40
- 230000001105 regulatory effect Effects 0.000 claims abstract description 16
- 108010076504 Protein Sorting Signals Proteins 0.000 claims abstract description 12
- 241000196324 Embryophyta Species 0.000 claims description 54
- 239000002773 nucleotide Substances 0.000 claims description 16
- 125000003729 nucleotide group Chemical group 0.000 claims description 16
- 241000701489 Cauliflower mosaic virus Species 0.000 claims description 6
- 239000011159 matrix material Substances 0.000 claims description 6
- 102200111112 rs397514590 Human genes 0.000 claims description 5
- 102220092319 rs876657875 Human genes 0.000 claims description 5
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 2
- 239000003623 enhancer Substances 0.000 claims description 2
- 238000013518 transcription Methods 0.000 claims description 2
- 230000035897 transcription Effects 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 14
- 210000003763 chloroplast Anatomy 0.000 abstract description 9
- 239000013598 vector Substances 0.000 description 38
- 239000012634 fragment Substances 0.000 description 15
- 239000007788 liquid Substances 0.000 description 15
- 244000061176 Nicotiana tabacum Species 0.000 description 13
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 13
- 230000001580 bacterial effect Effects 0.000 description 12
- 238000010367 cloning Methods 0.000 description 9
- 238000012258 culturing Methods 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 241000589158 Agrobacterium Species 0.000 description 8
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 238000009630 liquid culture Methods 0.000 description 8
- 101000798100 Bos taurus Lactotransferrin Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 102000018120 Recombinases Human genes 0.000 description 5
- 108010091086 Recombinases Proteins 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 5
- 229940072440 bovine lactoferrin Drugs 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 240000008415 Lactuca sativa Species 0.000 description 4
- 235000003228 Lactuca sativa Nutrition 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241001052560 Thallis Species 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 4
- 229960001225 rifampicin Drugs 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KRWTWSSMURUMDE-UHFFFAOYSA-N [1-(2-methoxynaphthalen-1-yl)naphthalen-2-yl]-diphenylphosphane Chemical compound COC1=CC=C2C=CC=CC2=C1C(C1=CC=CC=C1C=C1)=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 KRWTWSSMURUMDE-UHFFFAOYSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000012881 co-culture medium Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002363 herbicidal effect Effects 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000012021 retail method of payment Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000004960 subcellular localization Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000011426 transformation method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 2
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- -1 iron ions Chemical class 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000012883 rooting culture medium Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 241001416153 Bos grunniens Species 0.000 description 1
- 241000283699 Bos indicus Species 0.000 description 1
- 241000282828 Camelus bactrianus Species 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000748095 Hymenopappus filifolius Species 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229940027138 cambia Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- KXZOIWWTXOCYKR-UHFFFAOYSA-M diclofenac potassium Chemical compound [K+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KXZOIWWTXOCYKR-UHFFFAOYSA-M 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000010438 iron metabolism Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 239000009877 shengmai Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The invention discloses a lactoferrin plant expression vector for stably and efficiently expressing a lactoferrin gene and application thereof. The invention locates the target protein in plant leaf chloroplast by optimizing expression regulating element, adding proper signal peptide sequence, etc. to raise the expression amount and stability of target protein by 5-10 times, raise the expression amount of target protein from microgram level to milligram level and reach about 1 mg/g. Realizes stable and efficient expression of the lactoferrin in the leaves.
Description
Field of the art
The invention relates to a lactoferrin plant expression vector and application.
(II) background art
Lactoferrin (Lactoferrin) is an iron binding protein that is widely found in mammalian milk and other body fluids. It plays an important role in protecting and regulating milk, and has various physiological activities and application potential.
Lactoferrin has several main properties:
iron binding: lactoferrin can bind and transport iron ions and play a role in regulating the iron metabolism of the body. It can bind with excessive free iron, reduce damage to cells and tissues from free iron, and release iron ions when needed.
Antibacterial action: lactoferrin has broad-spectrum antibacterial activity and can inhibit the growth of bacteria, fungi and viruses. It exerts an antibacterial effect through a variety of mechanisms including binding to anions on the surface of microorganisms, disrupting bacterial membranes, inhibiting synthesis of bacterial inner and outer membranes, and the like.
Immunomodulatory effects: lactoferrin can regulate the function of the immune system and enhance the body's resistance. It is involved in regulating inflammatory responses, stimulating activation and proliferation of immune cells, and promoting interactions between immune cells.
Antioxidant effect: lactoferrin has antioxidant activity, and is capable of scavenging free radicals and protecting cells from oxidative damage. It plays an important role in maintaining the redox balance of cells and protecting the integrity of cell membranes.
Based on the physiological activity and multiple functions of lactoferrin, the lactoferrin has wide application potential in the fields of medicines, health products, foods, cosmetics and the like. Some studies have shown that lactoferrin can be used to treat anaemia, iron deficiency diseases, infectious diseases, etc., and is also used as an ingredient of antibacterial agents, immunomodulators, antioxidants and nutraceuticals. In addition, lactoferrin is also widely used in the fields of infant formula milk powder, functional foods, oral care products, skin care products and the like.
Therefore, the research and development of lactoferrin has important scientific significance and application value, including searching for efficient production methods, exploring the bioactive mechanism thereof, optimizing the functional application thereof and the like.
Currently, plant leaf expression of lactoferrin still presents challenges and problems, mainly including the following:
the expression level is low: plant leaves are used as main tissues for expressing lactoferrin, and the natural expression level of the plant leaves is often low, so that the requirement of large-scale production cannot be met. Thus, increasing the expression level of lactoferrin in plant leaves is a critical issue.
Protein stability: lactoferrin may be degraded in plant leaves by protein degrading enzymes, resulting in a decrease in its stability. This may lead to inactivation of lactoferrin or reduce its biological activity.
Subcellular localization: the subcellular localization of lactoferrin within cells has a significant impact on its function and use. Ensuring that lactoferrin is correctly located in the plant leaf to a suitable subcellular location, such as the cytosol, endoplasmic reticulum or cell wall, has an important impact on its biological activity and application.
Purifying and extracting: purification and extraction of lactoferrin from plant leaves is a challenging step. Leaves contain a large amount of other proteins and complex components such as chlorophyll and the like, and efficient purification and extraction methods are required to obtain high purity lactoferrin.
Research is underway to solve these problems. Such as by optimizing plant gene expression systems, regulating transcription factors and signaling pathways, improving protein stability and subcellular localization, and developing efficient purification techniques, these challenges can be overcome, and the efficiency and quality of lactoferrin expressed by plant leaves can be improved, thereby promoting the use of lactoferrin in plant systems. Therefore, a method for improving the high-volume stable expression of lactoferrin in the leaves is needed.
(III) summary of the invention
The invention aims to provide a lactoferrin plant expression vector and application, which are used for improving the expression quantity of lactoferrin in plants by optimizing expression regulatory elements, applying proper signal peptide and other modes, so as to realize the expression of lactoferrin in chloroplasts, thereby improving the expression quantity of lactoferrin on one hand and the stability of target protein on the other hand.
The technical scheme adopted by the invention is as follows:
the invention provides a lactoferrin plant expression vector for stably and efficiently expressing a lactoferrin gene, wherein the lactoferrin plant expression vector comprises a lactoferrin gene sequence capable of being expressed by plants, a signal peptide coding gene sequence, a promoter and a transcription terminator.
Furthermore, the lactoferrin gene is bovine lactoferrin gene, but is optimized according to plant codon preference, the nucleotide sequence is shown as SEQ ID NO. 1, and the amino acid sequence of the encoded protein is shown as SEQ ID NO. 2.
Further, the nucleotide sequence of the signal peptide coding gene is shown as SEQ ID NO. 3, and the amino acid sequence is shown as SEQ ID NO. 4.
Further, the promoters include, but are not limited to, the cauliflower mosaic virus CaMV35S promoter P35S, the nucleotide sequence of which is shown in SEQ ID NO. 5; the terminator sequence includes but is not limited to cauliflower mosaic virus CaMV35S terminator T35S, and the nucleotide sequence of the terminator is shown in SEQ ID NO. 6.
The lactoferrin provided by the invention can also be derived from other animal genomes, the amino acid sequences of the proteins encoded by the lactoferrin genes are shown in table 1, and the lactoferrin genes provided by the invention comprise but are not limited to the genes and homologous genes thereof.
Table 1: protein encoded by animal lactoferrin gene
Numbering device | Animal of origin | Animal Latin name | NCBI sequence |
1 | Cattle | Bos taurus | NP_851341.1 |
2 | Yak | Bos grunniens | ALE66311.1 |
3 | (Cattle) | Bos indicus | ACY01187.1 |
4 | Human body | Homo sapiens | AAB60324.1 |
5 | Pig | Sus scrofa | XP_020924222.1 |
6 | Sheep | Ovis aries | NP_001020033.1 |
7 | Camel with top | Camelus bactrianus | XP_010965654.1 |
Furthermore, the expression vector of the invention also comprises a regulatory element for enhancing the expression quantity or stability of the herbicide resistant gene of a plant source, wherein the regulatory element refers to a nucleotide sequence capable of regulating the gene expression, and comprises an enhancer, a matrix attachment region sequence and the like, preferably a matrix attachment region sequence (MAR), and the nucleotide sequence is SEQ ID No: shown at 7. The regulatory element is arranged at the 5 'end of the plant source herbicide resistance gene expression frame or the 3' end of the terminator.
The basic vector used in the present invention to provide the backbone of the expression vector may be a pCambia series vector (CAMBIA, canberra, australia) or other vector, preferably a pCambia1300 vector. The selectable marker used in the present invention is the hygromycin resistance gene hyg carried by pCambia1300, alternatively the selectable marker gene may be a herbicide resistance gene or other resistance gene derived from bacteria or plants.
The invention provides application of a lactoferrin gene plant expression vector in improving the expression level of plant lactoferrin.
The invention provides an application of a lactoferrin gene plant expression vector in preparing lactoferrin, which is to transfer the lactoferrin gene plant expression vector into a plant genome to obtain a lactoferrin-enriched plant and extract the lactoferrin.
The expression vector constructed by the invention is suitable for the expression of monocotyledonous plants or dicotyledonous plants, and the monocotyledonous plants comprise: corn, rice, etc.; dicotyledonous plants include: soybean, rape, cotton, mulberry, etc.
The invention also provides a plant cell containing the lactoferrin gene plant expression vector T-DNA.
The invention also provides a plant containing the lactoferrin gene plant expression vector T-DNA.
The invention further provides a method for obtaining plant cells or plants for stably and efficiently expressing lactoferrin genes by using the expression vector, wherein the method can be an agrobacterium-mediated transformation method, a gene gun method, a protoplast infection method or other plant genetic transformation methods, and preferably the agrobacterium-mediated transformation method.
Compared with the prior art, the invention has the beneficial effects that: the invention locates the target protein in plant leaf chloroplast by optimizing expression regulating element, adding proper signal peptide sequence, etc. to raise the expression amount and stability of target protein by 5-10 times, raise the expression amount of target protein from microgram level to milligram level and reach about 1 mg/g. Realizes stable and efficient expression of the lactoferrin in the leaves.
(IV) description of the drawings
Fig. 1: schematic of T-DNA structure of BLF plant expression vector. P35S is CaMV35S promoter, T35S is CaMV35S terminator, BLF is codon optimized BLF gene, hyg is hygromycin resistance gene, CTP is chloroplast signal peptide, MAR is matrix attachment region sequence (MAR).
(fifth) detailed description of the invention
The invention will be further described with reference to the following specific examples, but the scope of the invention is not limited thereto:
modifications and substitutions of steps, methods, or conditions of the present invention without departing from the spirit of the invention are intended to be within the scope of the present invention. The technical means used in the examples are conventional means well known to those skilled in the art unless otherwise indicated.
Example 1, vector construction
To construct the vectors required in the present invention, the following sequences were synthesized artificially: 1) The nucleotide sequence of the codon optimized bovine lactoferrin gene BLF is shown as SEQ ID No:1, the amino acid sequence is shown as SEQ ID No:2 is shown in the figure; 2) The nucleotide sequence of the chloroplast signal peptide CTP is shown as SEQ ID No:3, the amino acid sequence is shown as SEQ ID No:4 is shown in the figure; 3) The cauliflower mosaic virus CaMV35S promoter P35S has a nucleotide sequence shown in SEQ ID NO. 5; 4) The nucleotide sequence of the cauliflower mosaic virus CaMV35S terminator T35S is shown in SEQ ID NO. 6; 5) A matrix attachment region sequence (MAR) having a nucleotide sequence set forth in SEQ ID No: shown at 7.
1. Lactoferrin control expression vector 1300-p35S-BLF-T35S construction
(1) The vector 1300 from which the hygromycin gene was deleted was recovered by digestion of pCambia1300 with restriction enzyme XhoI using pCambia1300 vector (NCBI Accession Number: AF 234296) as the starting vector;
(2) The BLF gene (primer BLF-F, BLF-R) was obtained by PCR cloning using the artificially synthesized BLF genome as a template.
(3) And then, connecting the vector recovered in the step (1) and the BLF gene fragment in the step (2) by utilizing recombinase, and cloning to obtain a transitional vector p35S-BLF-T35S.
(4) Then, the pCambia1300 vector was subjected to double cleavage with restriction enzymes BamHI and EcoRI, and the cleaved vector was recovered.
(5) The plasmid DNA of the transition vector p35S-BLF-T35S was used as a template, and the BLF gene expression cassette (primer SBLF-F, SBLF-R) was cloned by PCR to recover a p35S-CTP-BLF-T35S fragment having a fragment size of about 3.0 kb.
(6) And then cloning after connecting the vector recovered in the step (4) and the p35S-CTP-BLF-T35S fragment in the step (5) by utilizing recombinase to obtain a final vector 1300-p35S-BLF-T35S.
BLF-F:5’-CTCTCTACAAATCTATCTCTAAAGAACAATGGCCCCACGCAAGAA CGTG;
BLF-R:5’-CACACATTATTATGGAGAAATCATTAGCGGGTGAGGAAGGCGCAG GCC;
SBLF-F:5’-CTGCAGGTCGACTCTAGAGGATCCTAGAGCAGCTTGCCAACATGSBLF-R:5’-CAGCTATGACCATGATTACGTAATTCGGGGGATCTGGATTTTAG
2. Construction of optimized lactoferrin expression vector 1300-p35S-CTP-BLF-T35S
(1) The vector 1300 from which the hygromycin gene had been deleted was recovered by digestion of pCambia1300 with the restriction enzyme XhoI using the pCambia1300 vector (NCBI Accession Number: AF 234296) as the starting vector.
(2) The BLF gene (primer BLF-F, BLF-R) was obtained by PCR cloning using the artificially synthesized DNA of the nucleotide sequence of the BLF gene as a template, and a BLF fragment having a fragment size of about 2.1kb was recovered.
(3) The CTP polypeptide coding sequence DNA synthesized manually is used as a template, CTP fragments (primer CTP-F, CTP-R) are obtained through PCR cloning, and CTP fragments with the fragment size of about 0.25kb are recovered;
(4) And then cloning the vector recovered in the step (1), the BLF fragment in the step (2) and the CTP fragment in the step (3) after three-section connection by utilizing recombinase to obtain a transitional vector p35S-CTP-BLF-T35S.
(5) Then, the pCambia1300 vector was subjected to double cleavage with restriction enzymes BamHI and EcoRI, and the cleaved vector was recovered.
(6) The plasmid DNA of the transition vector p35S-CTP-BLF-T35S was used as a template, and the BLF gene expression cassette (primer SCBLF-F, SCBLF-R) was cloned by PCR to recover a p35S-CTP-BLF-T35S fragment having a fragment size of about 3.3 kb.
(7) And (3) connecting the vector recovered in the step (5) and the fragment in the step (6) by utilizing recombinase, and cloning to obtain the final vector 1300-p35S-CTP-BLF-T35S.
BLF-F:5’-CAGCTGCTAAGGCTGAGGCCCCACGCAAGAACGTGC;
BLF-R:5’-CACACATTATTATGGAGAAATCATTAGCGGGTGAGGAAGGCGCAG GCC;
CTP-F:5’-CTCTCTACAAATCTATCTCTAAAGAACAATGGCTGCTACTATGGCT TC;
CTP-R:5’-GCCTCAGCCTTAGCAGCTGGAGCAGCAACAGAAGAAGAAG;
SCBLF-F:5’-CTGCAGGTCGACTCTAGAGGATCCTAGAGCAGCTTGCCAACAT G;
SCBLF-R:5’-CAGCTATGACCATGATTACGTAATTCGGGGGATCTGGATTTTAG
3. Construction of lactoferrin expression vector 1300-MAR-p35S-CTP-BLF-T35S optimized by adding expression regulatory element
(1) Double-enzyme cutting is carried out on the 1300-p35S-CTP-BLF-T35S vector by using restriction enzymes BamHI and HindIII, and the carrier after enzyme cutting is recovered;
(2) MAR fragments (primer MAR-F, MAR-R) were obtained by PCR cloning using the artificially synthesized MAR nucleotide sequence DNA as a template, and MAR fragments having a fragment size of about 1.2kb were recovered.
(3) And then cloning after connecting the vector recovered in the step (1) and the MAR fragment in the step (2) by utilizing recombinase to obtain a final vector 1300-MAR-p35S-CTP-BLF-T35S.
MAR-F:5’-GTAAAACGACGGCCAGTGCCAAGCTTGATTAAAAATCCCAATTAT ATTTGG;
MAR-R:5’-CATGTTGGCAAGCTGCTCTAGGATCCACTATTTTCAGAAGAAGTT CC。
4. Obtaining Agrobacterium containing T-DNA vector
The obtained T-DNA vectors (1300-p 35S-BLF-T35S, 1300-p35S-CTP-BLF-T35S and 1300-MAR-p 35S-CTP-BLF-T35S) are subjected to electric shock transformation with agrobacterium EHA105, strains containing plant transformation vectors are obtained through kan screening, and the strains are stored to a-80 ℃ refrigerator after glycerol is added for transgenic crop infection.
Example 2 tobacco conversion
(1) The Agrobacterium of example 1 (1300-p 35S-BLF-T35S, 1300-p35S-CTP-BLF-T35S and 1300-MAR-p 35S-CTP-BLF-T35S) was streaked onto YEP plates containing 1mg/L kanamycin and 1mg/L rifampicin, incubated at 28℃for 2 days, single colonies were picked from the plates, inoculated into 20mL of YEP liquid medium containing 50mg/L kanamycin (kan) and 50mg/L rifampicin (Rif), and incubated on a thermostated shaking bed at 180r/min to an OD of 0.8 (approximately 17 h) at 28 ℃.
(2) Transferring the bacterial liquid with the OD600 of 0.8 in the step (1) into a newly prepared YEP liquid culture medium containing 50mg/L of Rif according to the proportion of 1.5% of volume concentration, and simultaneously adding 400 mu mol/L of acetosyringone. The culture was continued under the same conditions for another 6 hours, and transformation was started when the OD600 was 0.5.
(3) And (3) 50mL of the bacterial liquid with the OD600 of 0.5 in the step (2) is subjected to centrifugal precipitation at 4 ℃ and 2500r/min, the bacterial liquid is resuspended in 40mL of MS liquid culture medium on an ultra-clean workbench, the resuspended bacterial liquid is poured into a glass plate, tobacco leaves (tobacco germinated for about one month) cut into 5X 5mm size are put into the bacterial liquid, soaked for 10min, and the leaves are taken out and placed on sterile filter paper to absorb the attached bacterial liquid to be used as explants.
(4) The explant from step (3) was placed on RMOP medium and co-cultured for 3 days at 28℃under dark culture conditions.
(5) The explant subjected to the co-culture in the step (4) is transferred to an RMOP medium (500 mg/L of carbenicillin is added to inhibit the growth of the agrobacteria) to which an antibiotic (20 mg/L hyg (hygromycin)) is added, and the selection culture is performed under the conditions of 25 mu mol.m.s and 25 ℃.
(6) After 2-3 weeks of selective culture, the transformed cells of the explants will differentiate resistant adventitious buds or produce resistant callus, and these resistant material will be transferred to corresponding selective medium (RMOP+20 mg/L hyg+500mg/L Cb (carbicillin)) for subculture at 26 ℃.
(7) When the adventitious bud length of the step (6) is more than 1cm, cutting and inserting the adventitious bud length into a tobacco rooting culture medium (MS+0.1 mg/L NAA+100mg/L kan+500mg/L Cb) containing selective pressure (10 mg/L hygromycin), carrying out rooting culture at 26 ℃ for about two weeks to grow adventitious roots, and carrying out molecular identification after the adventitious roots grow slightly longer.
Example 3 detection of lactoferrin expression level in tobacco leaves
To detect the expression level of bovine lactoferrin in tobacco leaves in example 2, we purchased a bovine lactoferrin ELISA detection kit (abcam, bovine Lactoferrin ELISA Kit (ab 274406)).
Method for checking the expression level of BLF gene in tobacco: cutting 0.1g leaf into pieces, adding 1-1.5mL PBS, grinding in a homogenizer, and strictly operating according to the specification of BLF protein detection kit (ab 274406). Specifically, the sample extract was diluted 500-fold with 1×pbs. The same tissue extract of non-transgenic tobacco plants containing the same dilution fold was used as a control to detect background signals due to the test tissue. Each elisa plate contained BLF standard of known concentration for generating a standard curve (curve equation y= 1.2769 ×)
(1.0151-e -0.0329x) ). Each ELISA plate contains a blank buffer for detecting the background signal of the extraction buffer. Abcam corporation kit (cat No. ab 274406) was used to detect BLF content. Samples, controls and standards were added to the elisa plate and incubated for 30 minutes at room temperature. Then, the elisa plates were washed, an antibody conjugate solution was added to each of the elisa plates, and incubated at room temperature for 30 minutes. After antibody conjugation incubation, the elisa plate was washed. The substrate solution was added to the elisa plate and incubated at room temperature for 30 minutes. After incubation, the reaction is reversedThe stop solution was added to the ELISA plate, and the OD value was read at 450 and nm, and converted to the expression level according to the standard curve equation (Table 2).
TABLE 2 average BLF Gene content in different tobacco leaves (. Mu.g/g.+ -. SD)
Note that: fresh weight mean, standard deviation and measurement ranges are based on all readings for each tissue type (n=3 different leaves). Student-t test analysis was performed on the mean values of each group, with differences in letters indicating the presence of a significant difference (p < 0.05) between the two groups of data.
As can be seen from Table 2, the average expression level of the BLF gene in the leaf of vector 1300-p35S-CTP-BLF-T35S is significantly higher than that in the leaf of vector 1300-p35S-BLF-T35S, indicating that the chloroplast signal peptide CTP significantly increases the expression level of BLF in tobacco leaf. At the same time, the carrier
The average expression level of the BLF gene in the leaf of 1300-MAR-p35S-CTP-BLF-T35S is obviously higher than that of the vector 1300-p35S-CTP-BLF-T35S, which indicates that the application of the expression control element MAR further obviously improves the expression level of the BLF in tobacco leaves.
Therefore, compared with the common expression vector (1300-p 35S-BLF-T35S), the expression level of BLF in tobacco leaves can be obviously improved by utilizing the chloroplast signal peptide CTP in the invention, and meanwhile, on the basis, the expression level of BLF in tobacco leaves can be further improved by utilizing regulatory elements such as MAR and the like.
Example 4 lettuce transformation and measurement of Lactoferrin expression level in lettuce leaves
Agrobacterium EHA105 constructed in example 2 containing the expression vectors 1300-p35S-BLF-T35S, 1300-p35S-CTP-BLF-T35S and 1300-MAR-p35S-CTP-BLF-T35S, respectively, was streaked onto YEP plates containing 1mg/L kanamycin and 1mg/L rifampicin frozen at-80℃and cultured overnight at 28 ℃. Picking single colony, inoculating in YEP liquid culture medium, shake culturing at 28deg.C and 220r/min until bacterial liquid concentration is OD600 about 1.0; and (3) centrifuging at 4000r/min for 5min, collecting thalli, washing twice by using a 1/2MS liquid culture medium, and re-suspending in the 1/2MS liquid culture medium to dilute the thalli until the OD600 is 0.6, thus obtaining the dip dyeing liquid.
Cutting the edge of sterile lettuce seedling She Qiequ into 3-6 mm 2 Leaf discs of (2) are subjected to dip dyeing for 20 minutes at room temperature in a dip dyeing liquid; sterilizing filter paper, sucking bacterial liquid, inoculating to co-culture Medium (MS), culturing at 28deg.C for 3d, inoculating to bud induction screening medium (MS+1.5 mg/L6-BA+0.2mg/L IAA+20mg/L Hyg+300mg/L Cb), culturing at 25deg.C under 2000lx illumination intensity, and culturing under illumination for 14 h/d. The differentiated shoots were excised and inserted into 1/2MS medium (30 mg/L, 20mg/L Hyg and 300mg/L Cb for sucrose addition) to induce rooting at 26 ℃.
The bovine lactoferrin ELISA test kit (abcam, bovine LactoferrinELISAKit (ab 274406)) of example 3 was used to test the expression level of bovine lactoferrin in lettuce leaves, and the results are shown in Table 3.
TABLE 3 average BLF Gene content in different raw vegetable leaves (. Mu.g/g.+ -.SD)
Note that: fresh weight mean, standard deviation and measurement ranges are based on all readings for each tissue type (n=3 different leaves). Student-t test analysis was performed on the mean values of each group, with differences in letters indicating the presence of a significant difference (p < 0.05) between the two groups of data.
As can be seen from Table 3, the average expression level of the BLF gene in the leaf of vector 1300-p35S-CTP-BLF-T35S is significantly higher than that in the leaf of vector 1300-p35S-BLF-T35S, indicating that the chloroplast signal peptide CTP significantly increases the expression level of BLF in the leaf of Shengmai. At the same time, the carrier
The average expression level of the BLF gene in the 1300-MAR-p35S-CTP-BLF-T35S leaf is obviously higher than that in the vector 1300-p35S-CTP-BLF-T35S leaf, which indicates that the application of the expression control element MAR further obviously improves the expression level of the BLF in the raw vegetable leaf.
Therefore, compared with the common expression vector (1300-p 35S-BLF-T35S), the expression level of BLF in the raw vegetable leaves can be obviously improved by utilizing the chloroplast signal peptide CTP in the invention, and meanwhile, on the basis, the expression level of BLF in the raw vegetable leaves can be further improved by utilizing regulatory elements such as MAR and the like.
Example 5 Mulberry transformation
Agrobacterium EHA105 constructed in example 2 containing the expression vectors 1300-p35S-BLF-T35S, 1300-p35S-CTP-BLF-T35S and 1300-MAR-p35S-CTP-BLF-T35S, respectively, was streaked onto YEP plates containing 1mg/L kanamycin and 1mg/L rifampicin frozen at-80℃and cultured overnight at 28 ℃. Picking single colony, inoculating in YEP liquid culture medium, shake culturing at 28deg.C and 220r/min until bacterial liquid concentration is OD600 about 1.0; and (3) centrifuging at 4000r/m for 5min, collecting the thalli, washing twice by using a 1/2MS liquid culture medium, and re-suspending in the 1/2MS liquid culture medium to dilute the thalli until the OD600 is 0.3, thus obtaining the dip dyeing liquid.
Immersing a cut leaf disc in a dye solution under sterile conditions, slightly oscillating, immersing for 1h at room temperature, taking out the leaf disc, sucking redundant bacterial liquid on sterile filter paper, inoculating to a co-culture medium (MS+TDZ1.0 mg/L+NAA0.2 mg/L+fructose 20 g/L+agar powder 5g/L; pH5.8), co-culturing for 2d at 26 ℃, washing the leaf disc with a liquid co-culture medium (MS+TDZ1.0 mg/L+NAA0.2 mg/L+fructose 20g/L; pH5.8) for 3 times to remove excessive agrobacterium, transferring to a primary screening medium (MS+TDZ1.0 mg/L+NAA0.2 mg/L+hyg+Cef 400 mg/L+fructose 20 g/L+agar powder 5g/L; pH5.8), culturing for 15-30 d at 26 ℃, replacing the medium once every 7 times, and transferring the leaf disc to a secondary screening medium (MS+TDZ1.0.0 mg/L+NAA0.2 mg/L+NAA0+2 mg/L+fruit powder 5.2 mg/L+fruit powder 5 g/L) when the leaf disc starts growing and culturing for a callus or transferring to the secondary screening medium (NAA0.0+0.0+0.2 mg/L+NAA0+0.2+0+5.2 mg/L). Culturing at 26 ℃ and carrying out 25d secondary culture.
When the hygromycin buds screened for the second time grow to 2cm high, transferring the hygromycin buds into a rooting culture medium (1/2MS+NAA0.5 mg/L+BA 2.0mg/L+hyg10 mg/L+Cef50mg/L+fructose 20 g/L+agar powder 5g/L; pH 5.8), inducing rooting at 26 ℃, and performing seedling hardening and transplanting to culture into complete plants.
It should also be noted that the above-recited list only illustrates a few embodiments of the present invention. The invention is not limited to the above embodiments, but may be extended and expanded in many ways. All extensions that one of ordinary skill in the art could directly derive from or envision from the disclosure of the present invention should be considered as the scope of the present invention.
Claims (10)
1. A lactoferrin plant expression vector for stably and efficiently expressing a lactoferrin gene, wherein the lactoferrin plant expression vector comprises a plant-expressible lactoferrin gene sequence, a signal peptide-encoding gene sequence, a promoter, and a transcription terminator.
2. The lactoferrin plant expression vector of claim 1, wherein the lactoferrin gene sequence is set forth in SEQ ID No. 1.
3. The lactoferrin plant expression vector of claim 1, wherein the signal peptide encoding gene sequence is shown in SEQ ID No. 3.
4. The lactoferrin plant expression vector of claim 1, wherein said promoter comprises a cauliflower mosaic virus CaMV35S promoter P35S and said terminator sequence comprises, but is not limited to, a cauliflower mosaic virus CaMV35S terminator T35S.
5. The lactoferrin plant expression vector of claim 4, wherein said promoter P35S nucleotide sequence is set forth in SEQ ID No. 5; the nucleotide sequence of the terminator T35S is shown in SEQ ID NO. 6.
6. The lactoferrin plant expression vector of claim 1, wherein said expression vector comprises a regulatory element comprising an enhancer, matrix attachment region sequence.
7. The lactoferrin plant expression vector of claim 6, wherein said regulatory element is a matrix attachment region sequence and the nucleotide sequence is SEQ ID No: shown at 7.
8. Use of the lactoferrin gene plant expression vector of claim 1 to increase the expression level of lactoferrin in plants.
9. Use of a lactoferrin gene plant expression vector of claim 1 in the preparation of lactoferrin.
10. A plant cell comprising the lactoferrin gene plant expression vector T-DNA of claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310885128.XA CN116694680A (en) | 2023-07-19 | 2023-07-19 | Lactoferrin plant expression vector for stably and efficiently expressing lactoferrin gene and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310885128.XA CN116694680A (en) | 2023-07-19 | 2023-07-19 | Lactoferrin plant expression vector for stably and efficiently expressing lactoferrin gene and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116694680A true CN116694680A (en) | 2023-09-05 |
Family
ID=87845335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310885128.XA Withdrawn CN116694680A (en) | 2023-07-19 | 2023-07-19 | Lactoferrin plant expression vector for stably and efficiently expressing lactoferrin gene and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116694680A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118406716A (en) * | 2024-07-01 | 2024-07-30 | 山东大益生物科技集团有限公司 | Method for expressing and producing bovine lactoferrin in tobacco by cytoplasmic localization |
-
2023
- 2023-07-19 CN CN202310885128.XA patent/CN116694680A/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118406716A (en) * | 2024-07-01 | 2024-07-30 | 山东大益生物科技集团有限公司 | Method for expressing and producing bovine lactoferrin in tobacco by cytoplasmic localization |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001006844A1 (en) | Method for superrapid transformation of monocotyledon | |
EP2980214B1 (en) | Agrobacterium bacterium to be used in plant transformation method | |
AU2018280528B2 (en) | Method for improving transformation efficiency of plant and method for transforming plant | |
CN116694680A (en) | Lactoferrin plant expression vector for stably and efficiently expressing lactoferrin gene and application | |
AU2015321438A1 (en) | Method for transforming a plant cell or plant tissue using Agrobacterium, transgenic plant, transgenic cell or transgenic tissue, culture medium and use of a method for transforming a plant cell or tissue | |
CN112626111A (en) | Herbicide resistance gene expression vector and application thereof | |
JPWO2008117537A1 (en) | Transpiration inhibitor | |
JP3141084B2 (en) | Ultra-rapid transformation of monocotyledonous plants | |
JP4581098B2 (en) | Methods for expressing and accumulating peptides in plants | |
CN116904475A (en) | Vector for stably and efficiently expressing lactoferrin gene and application thereof | |
MX2010011452A (en) | Transformation and engineered trait modification in miscanthus species. | |
Cunningham et al. | Recombinant proteins from plants | |
CN107109432A (en) | The method for producing plastid transformation body | |
CA2291932C (en) | A method for producing the transformants of coffee plants and transgenic coffee plants | |
KR101198648B1 (en) | Method for transforming Cucumis sativus line through direct shoot induction and Cucumis sativus line transformant produced by the same | |
CN115820689B (en) | Method for improving NMN content in vegetables by polygene tandem method and application thereof | |
US9796981B2 (en) | Methods for transforming tarwi and for producing molecular farming products in transgenic tarwi seed | |
CN118516376B (en) | Application of HbSHB gene in improving genetic transformation efficiency of rubber tree and construction method of expression vector of HbSHB gene | |
CN117126849A (en) | DNA sequence, expression vector and application | |
JP2006022062A (en) | Growth promoter | |
CN117986331A (en) | Application of DRW1 protein or substance for regulating expression of DRW1 protein in regulation of salt tolerance of rice | |
KR101368284B1 (en) | Method for producing transgenic reed plant and the plant thereof | |
CN118497259A (en) | SlRIK1 gene and application of protein thereof in immune regulation of tomato bacterial wilt | |
KR20050048503A (en) | Recombinant expression vector for production of plants having multiple stress tolerances, and method for preparing multiple stress-tolerant plants using the same | |
CN116425844A (en) | Platycladus orientalis transcription factor PoWRKY2, encoding gene PoWRKY2, recombinant plasmid, recombinant bacterium and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230905 |